Andreoli, L, Bertsias, GK, Agmon-Levin, N, Brown, S, Cervera, R, Costedoat-Chalumeau, N, et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76:476–485.Google Scholar

Østensen, M, Andreoli, L, Brucato, A, Cetin, I, Chambers, C, Clowse, MEB, et al. State of the art: Reproduction and pregnancy in rheumatic diseases. Autoimmun Rev. 2015 May;14:376–386.Google Scholar

Lazzaroni, MG, Dall’Ara, F, Fredi, M, Nalli, C, Reggia, R, Lojacono, A, Ramazzotto, F, Zatti, S, Andreoli, L, Tincani, A. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun. 2016;74:106–117.Google Scholar

Tincani, A, Dall’Ara, F, Lazzaroni, MG, Reggia, R, Andreoli, L. Pregnancy in patients with autoimmune disease: A reality in 2016. Autoimmun Rev. 2016;15:975–977.Google Scholar

Knight, CL, Nelson-Piercy, C. Management of systemic lupus erythematosus during pregnancy: Challenges and solutions. Open access Rheumatol Res Rev. 2017;9:37–53.Google ScholarPubMed

Machen, L, Clowse, MEB. Vasculitis and pregnancy. Rheum Dis Clin North Am. 2017;43:239–247.Google Scholar

Petri, M, Orbai, A-M, Alarcón, GS, Gordon, C, Merrill, JT, Fortin, PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheum. 2012;64(8):2677–2686.Google Scholar

Dooley, MA, Jayne, D, Ginzler, EM, Isenberg, D, Olsen, NJ, Wofsy, D, et al. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med. 2011;365:1886–1895.Google Scholar

Houssiau, FA, D’Cruz, D, Sangle, S, Remy, P, Vasconcelos, C, Petrovic, R, et al. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial. Ann Rheum Dis. 2010;69:2083–2089.Google Scholar

Buyon, JP, Kim, MY, Guerra, MM, Laskin, CA, Petri, M, Lockshin, MD, et al. Predictors of pregnancy outcomes in patients with lupus: A cohort study. Ann Intern Med. 2015;163:153–163.Google Scholar

Moroni, G, Doria, A, Giglio, E, Imbasciati, E, Tani, C, Zen, M, et al. Maternal outcome in pregnant women with lupus nephritis: A prospective multicenter study. J Autoimmun. 2016.Google Scholar

Moroni, G, Doria, A, Giglio, E, Tani, C, Zen, M, Strigini, F, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun. 2016;74:6–12.Google Scholar

Manger, K, Wildt, L, Kalden, JR, Manger, B. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: The PREGO-Study. Autoimmun Rev. 2006;5:269–272.Google Scholar

Houssiau, FA, Vasconcelos, C, D’Cruz, D, Sebastiani, GD, Garrido, E de R, Danieli, MG, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis. 2010;69:61–64.Google Scholar

Tamirou, F, Nieuwland Husson, S, Gruson, D, Debiève, F, Lauwerys, BR, Houssiau, FA. The low-dose intravenous cyclophosphamide Euro-Lupus regimen does not impact the ovarian reserve, as measured by serum anti-Müllerian hormone levels. Arthritis Rheumatol. 2017. http://doi.wiley.com/10.1002/art.40079.Google Scholar

Nahata, L, Sivaraman, V, Quinn, GP. Fertility counseling and preservation practices in youth with lupus and vasculitis undergoing gonadotoxic therapy. Fertil Steril. 2016;106:1470–1474.CrossRefGoogle ScholarPubMed

Smyth, A, Oliveira, GHM, Lahr, BD, Bailey, KR, Norby, SM, Garovic, VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010; 5:2060–2068.Google Scholar

Götestam Skorpen, C, Hoeltzenbein, M, Tincani, A, Fischer-Betz, R, Elefant, E, Chambers, C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795–810.Google Scholar

Clowse, MEB, Magder, L, Witter, F, Petri, M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54:3640–3647.CrossRefGoogle ScholarPubMed

Kaplan, YC, Ozsarfati, J, Nickel, C, Koren, G. Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: A systematic review and meta-analysis. Br J Clin Pharmacol. 2016;81:835–848.CrossRefGoogle ScholarPubMed

Levy, R, Vilela, V, Cataldo, M, Ramos, R, Duarte, J, Tura, B, et al. Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebo-controlled study. Lupus. 2001;10:401–404.Google Scholar

Sperber, K, Hom, C, Chao, CP, Shapiro, D, Ash, J, Aberientos, C. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J. 2009;7:9.CrossRefGoogle ScholarPubMed

Fischer-Betz, R, Specker, C, Brinks, R, Aringer, M, Schneider, M. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatol. 2013; 52:1070–1076.CrossRefGoogle ScholarPubMed

Bateman, BT, Patorno, E, Desai, RJ, Seely, EW, Mogun, H, Dejene, SZ, et al. Angiotensin-converting enzyme inhibitors and the risk of congenital malformations. Obstet Gynecol. 2017;129:174–184.Google Scholar

Bundhun, PK, Soogund, MZS, Huang, F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: A meta-analysis of studies published between years 2001–2016. J Autoimmun. 2017. www.ncbi.nlm.nih.gov/pubmed/28256367.Google Scholar

Moroni, G, Ponticelli, C. Pregnancy in women with systemic lupus erythematosus (SLE). Eur J Intern Med. 2016;32:7–12.Google Scholar

Yelnik, CM, Laskin, CA, Porter, TF, Branch, DW, Buyon, JP, Guerra, MM, et al. Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: Validation of PROMISSE study results. Lupus Sci Med. 2016; 3.Google Scholar

Kim, MY, Buyon, JP, Guerra, MM, Rana, S, Zhang, D, Laskin, CA, et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: Results of the PROMISSE study. Am J Obstet Gynecol 2016;214:108.e1-108.e14. http://dx.doi.org/10.1016/j.ajog.2015.09.066.Google Scholar

Imbasciati, E, Surian, M, Bottino, S, Cosci, P, Colussi, G, Ambroso, GC, et al. Lupus nephropathy and pregnancy: A study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis. Nephron. 1984;36:46–51.Google Scholar

Day, C, Hewins, P, Hildebrand, S, Sheikh, L, Taylor, G, Kilby, M, et al. The role of renal biopsy in women with kidney disease identified in pregnancy. Nephrol Dial Transplant. 2008;23:201–206.Google Scholar

Webster, P, Webster, L, Cook, H, Horsfield, C, Seed, P, Vaz, R, et al. A multicentre cohort study of histological findings and long-term outcomes of kidney disease in women who have been pregnant. Clin J Am Soc Nephrol. 2017;12:408–416.Google Scholar

Bramham, K, Seed, PTPT, Lightstone, L, Nelson-Piercy, C, Gill, C, Webster, P, et al. Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int. 2016;89:874–885.Google Scholar

Bertsias, GK, Tektonidou, M, Amoura, Z, Aringer, M, Bajema, I, Berden, JH, Boletis, J, Cervera, R, Dorner, T, Doria, A, Ferrario, F, Floege, J, Houssiau, FA, Ioannidis, JP, Isenberg, DA, Kallenberg, CG, Lightstone, L, Marks, SD, Martini, A, Moroni, G, Neumann, I, Praga, M, Schneider, M, Starra, A, Tesar, V, Vasconcelos, C, van Vollenhoven, RF, Zakharova, H, Haubitz, M, Gordon, C, Jayne, D, Boumpas, DT. EULAR/ERA-EDTA recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012; 71: 1771–1782.Google Scholar

Edwards, JCW, Snaith, ML, Isenberg, DA. A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment. Ann Rheum Dis. 1987;46:773–776.Google Scholar

Badsha, H, Kong, KO, Lian, TY, Chan, SP, Edwards, CJ, Chng, HH. Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications. Lupus. 2002;11:508–513.Google Scholar

Zeher, M, Doria, a., Lan, J, Aroca, G, Jayne, D, Boletis, I, et al. Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis. Lupus. 2011;20:1484–1493.CrossRefGoogle ScholarPubMed

Webster, P, Lightstone, L, McKay, D, Josephson, MA. Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int. 2017; 91:1047–1056.Google Scholar

Webster, P, Wardle, A, Bramham, K, Webster, L, Nelson-Piercy, C, Lightstone, L. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus. 2015;23:1192–1196.Google Scholar

Perricone, R, De Carolis, C, Kroegler, B, Greco, E, Giacomelli, R, Cipriani, P, et al. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology. 2008;47:646–651.CrossRefGoogle ScholarPubMed

Mulhearn, B, Bruce, IN. Indications for IVIG in rheumatic diseases. Rheumatology (Oxford). 2015;54:383–391.Google Scholar

Webster, P, Nelson-Piercy, C, Lightstone, L. A complicated multisystem flare of systemic lupus erythematosus during pregnancy. BMJ Case Rep. 2017.Google Scholar

Kronbichler, A, Brezina, B, Quintana, LF, Jayne, DRW. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review. Autoimmun Rev. 2016;15:38–49.Google Scholar

Nelson-Piercy, C, Agarwal, S, Lams, B. Lesson of the month: Selective use of cyclophosphamide in pregnancy for severe autoimmune respiratory disease. Thorax. 2016;71:667–668.Google Scholar

Noviani, M, Wasserman, S, Clowse, MEB. Breastfeeding in mothers with systemic lupus erythematosus. Lupus. 2016;25:973–979.Google Scholar

Bramham, K, Chusney, G, Lee, J, Lightstone, L, Nelson-Piercy, C. Breastfeeding and tacrolimus: Serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol. 2013;8:563–567.Google Scholar

Youngstein, T, Mason, JC. Interleukin 6 targeting in refractory Takayasu arteritis: Serial noninvasive imaging is mandatory to monitor efficacy. J Rheumatol. 2013;40:1941–1944.CrossRefGoogle ScholarPubMed

Seyahi, E. Takayasu arteritis: an update. Curr Opin Rheumatol. 2017;29:51–56.CrossRefGoogle ScholarPubMed

Yates, M, Watts, RA, Bajema, IM, Cid, MC, Crestani, B, Hauser, T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583–1594.Google Scholar

Pagnoux, C, Guillevin, L, French Vasculitis Study Group, MAINRITSAN Investigators. Rituximab or azathioprine maintenance in ANCA-associated vasculitis. N Engl J Med. 2015;372:386–387.Google Scholar

Soh, MC, Nelson-Piercy, C. High-risk pregnancy and the rheumatologist. Rheumatology (Oxford). 2015;54:572–587.Google Scholar

Flint, J, Panchal, S, Hurrell, A, Van De Venne, M, Gayed, M, Schreiber, K, et al. Guidelines BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding – Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2016;55:1693–1697.Google Scholar

Mahadevan, U, Cucchiara, S, Hyams, JS, Steinwurz, F, Nuti, F, Travis, SPL, et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn’s and Colitis Organisation: Pregnancy and pediatrics. Am J Gastroenterol. 2011;106:214–223.Google Scholar

Comarmond, C, Mirault, T, Biard, L, Nizard, J, Lambert, M, Wechsler, B, et al. Takayasu arteritis and pregnancy. Arthritis Rheumatol. 2015;67:3262–3269.Google Scholar

Assad, APL, da Silva, TF, Bonfa, E, Pereira, RMR. Maternal and neonatal outcomes in 89 patients with Takayasu arteritis (TA): Comparison before and after the TA diagnosis. J Rheumatol. 2015;42:1861–1864.Google Scholar

Singh, N, Tyagi, S, Tripathi, R, Mala, YM. Maternal and fetal outcomes in pregnant women with Takayasu aortoarteritis: Does optimally timed intervention in women with renal artery involvement improve pregnancy outcome? Taiwan J Obstet Gynecol. 2015;54:597–602.CrossRefGoogle ScholarPubMed

Alpay-Kanitez, N, Omma, A, Erer, B, Artim-Esen, B, Gül, A, Inanç, M, et al. Favourable pregnancy outcome in Takayasu arteritis: A single-centre experience. Clin Exp Rheumatol.;33(2 Suppl. 89):S–7–10.Google Scholar

Gatto, M, Iaccarino, L, Canova, M, Zen, M, Nalotto, L, Ramonda, R, et al. Pregnancy and vasculitis: A systematic review of the literature. Autoimmunity Reviews. 2012;11:A447–59.CrossRefGoogle ScholarPubMed

Fredi, M, Lazzaroni, MG, Tani, C, Ramoni, V, Gerosa, M, Inverardi, F, et al. Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies. Autoimmunity Reviews 2015;14: 686–691.Google Scholar